Skye Bioscience annual debt-to-equity ratio
2019
2020
2021
2024
2025
Skye Bioscience Debt-to-Equity Ratio Growth & History (SKYE)
Skye Bioscience's debt-to-equity ratio was 0.01 for fiscal 2025.
View full Skye Bioscience company overviewSkye Bioscience annual debt-to-equity ratio history
| Fiscal year | Period ended | Debt-to-equity ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 0.01 | 0.01 | +104.43% |
| 2024 | 2024-12-31 | 0.01 | — | — |
| 2021 | 2021-12-31 | 0.03 | −2.04 | −98.67% |
| 2020 | 2020-12-31 | 2.07 | 1.36 | +192.46% |
| 2019 · Dec 31 | 2019-12-31 | 0.71 | — | — |
Skye Bioscience quarterly debt-to-equity ratio
Q4.19
Q2.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q3.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
| Fiscal quarter | Period ended | Debt-to-equity ratio | Change | YoY change |
|---|---|---|---|---|
| Q1 2026 | 2026-03-31 | 0.01 | −0.00 | −2.71% |
| Q4 2025 | 2025-12-31 | 0.01 | 0.01 | +104.43% |
| Q3 2025 | 2025-09-30 | 0.01 | 0.01 | +289.01% |
| Q2 2025 | 2025-06-30 | 0.01 | 0.01 | +193.05% |
| Q1 2025 | 2025-03-31 | 0.01 | 0.00 | +142.25% |
| Q4 2024 | 2024-12-31 | 0.01 | — | — |
| Q3 2024 | 2024-09-30 | 0.00 | −0.15 | −98.35% |
| Q2 2024 | 2024-06-30 | 0.00 | — | — |
| Q1 2024 | 2024-03-31 | 0.00 | — | — |
| Q3 2023 | 2023-09-30 | 0.15 | — | — |
| Q1 2022 | 2022-03-31 | 0.05 | −0.39 | −89.00% |
| Q4 2021 | 2021-12-31 | 0.03 | −2.04 | −98.67% |
| Q3 2021 | 2021-09-30 | 0.19 | −0.28 | −60.03% |
| Q2 2021 | 2021-06-30 | 0.54 | — | — |
| Q1 2021 | 2021-03-31 | 0.43 | — | — |
| Q4 2020 | 2020-12-31 | 2.07 | 1.36 | +192.46% |
| Q2 2020 | 2020-09-30 | 0.46 | — | — |
| Q4 2019 · Dec 31 | 2019-12-31 | 0.71 | — | — |
Skye Bioscience debt-to-equity ratio trends
Over the last five fiscal years, Skye Bioscience's debt-to-equity ratio decreased from 2.07 to 0.01, a change of −2.05. The latest reported quarter, Q1 2026, shows 0.01.
About the metric
What the debt-to-equity ratio means
The debt-to-equity ratio compares interest-bearing debt with shareholders’ equity. It helps show how much debt financing a company uses relative to its accounting equity, but useful comparison levels vary by industry.
Calculation and source
How debt-to-equity is calculated
TickerStat calculates debt-to-equity as total interest-bearing debt divided by SEC-reported shareholders’ equity for the same balance-sheet date. Total liabilities are not treated as debt, and periods with non-positive equity are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Skye Bioscience source filings ↗